Summary

India active pharmaceutical Ingredients market stood at USD11806.93 million in FY2021 and is expected to grow at a CAGR of 12.24% during the forecast period. This growth can be attributed to high growth of the biopharmaceutical sector in the country. Additionally, increasing geriatric population in India is further expected to boost the demand through FY2027. Furthermore, growing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory disorders, among others is going to boost the market.

According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million lives each year. The major drivers boosting the growth of the India active pharmaceutical ingredients market are the rising drug research and increase in development and manufacturing of drugs and the increasing uptake of biopharmaceuticals. Besides, the sudden outbreak and spread of COVID-19 pandemic across the globe, with India being severely hit by the pandemic crisis, also opened opportunities for the growth of India active pharmaceutical ingredients market. Due to the pandemic spread major countries boycotted China for trade as it was where the virus originated, similarly India also banned all kinds of imports and exports with China.

This led to development of manufacturing facilities in the country and improved the status of domestic players. Also, India being a major pharmaceutical hub witnessed demand from various countries across the globe for getting the medical supplies and drugs. This in turn positively influenced the growth of active pharmaceutical ingredients market in the country. Also, supportive government policies such as Atmanirbhar Bharat, Pharma Vision 2020, Production Linked Incentive Scheme, among others is further expected to create lucrative opportunities for the growth of overall pharmaceutical industry and India active pharmaceutical ingredients market.

The India active pharmaceutical ingredients market is segmented based on method of synthesis, source, therapeutic application, drug type, company, and region. Based on method of synthesis, the market is further segmented into synthetic and biological. The synthetic method of synthesis dominated the market with a share of 56.29% in FY2021 on account of the easy availability of raw materials and easier process for development of active pharmaceutical ingredients. While the biological method of synthesis segment is expected to grow at a rate of 13.21% during the forecast period owing to the growing demand for vaccines, monoclonal antibodies, recombinant proteins, biosimilars, among others.

Based on drug type, the market is further segmented into generics and innovators. Generics dominated the market with a share of 69.56% in FY2021 as the country also has a large pool of scientists and engineers with a potential to steer the industry ahead to greater heights. India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The Indian pharmaceutical industry accounts for 2nd largest number of Abbreviated New Drug Application.

Teva API India Limited, Pfizer Ltd., Ipca Laboratories Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Aurobindo Pharma Limited, Aarti Drugs Ltd., IOL Chemicals and Pharmaceuticals Limited, Divis Laboratories Ltd., Granules India Limited, Laurus Labs Ltd., Solara Active Pharma Sciences, GlaxoSmithKline Pharmaceuticals Ltd, are some of the major companies operating in the India active pharmaceutical ingredients market. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, research collaborations, joint ventures, and new product developments to sustain themselves amidst fierce competition.

Years considered for this report:
Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year: FY2022E
Forecast Period: FY2023F-FY2027F

Objective of the Study:
• To analyze historical growth in the market size of India active pharmaceutical ingredients market from FY2017 to FY2021.
• To estimate and forecast the market size of India active pharmaceutical ingredients market from FY2022 to FY2027 and growth rate until FY2027.
• To classify and forecast India active pharmaceutical ingredients market based on method of synthesis, source, therapeutic application, drug type, company, and regional distribution.
• To identify dominant region or segment in the India active pharmaceutical ingredients market.
• To identify drivers and challenges for India active pharmaceutical ingredients market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India active pharmaceutical ingredients market.
• To identify and analyze the profiles of leading players operating in India active pharmaceutical ingredients market.
• To identify key sustainable strategies adopted by market players in India active pharmaceutical ingredients market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India active pharmaceutical ingredients market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these segments for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
• Active Pharmaceutical Ingredients manufacturers/ suppliers/ distributors
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to Active Pharmaceutical Ingredients
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, India Active Pharmaceutical Ingredients market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• India Active Pharmaceutical Ingredients Market, By Method of Synthesis:
o Synthetic
o Biological
• India Active Pharmaceutical Ingredients Market, By Source:
o Contract Manufacturing Organizations
o In-house
• India Active Pharmaceutical Ingredients Market, By Therapeutic Application:
o Cardiovascular Diseases
o Anti-diabetic Drugs
o Oncology Drugs
o Neurological Disorders
o Musculoskeletal Disorders
o Others
• India Active Pharmaceutical Ingredients Market, By Drug Type:
o Generics
o Innovator
• India Active Pharmaceutical Ingredients Market, By Region:
o West
o South
o North
o East

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in India Active Pharmaceutical Ingredients market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs.

The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on India Active Pharmaceutical Ingredients Market
4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness
5.2. Preferred Source for Procuring Active Pharmaceutical Ingredients
5.3. Demand for Active Pharmaceutical Ingredients, By Therapeutic Area

6. Global Active Pharmaceutical Ingredients Market Overview

7. India Active Pharmaceutical Ingredients Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method of Synthesis (Synthetic v/s Biological)
7.2.2. By Source (Contract Manufacturing Organizations v/s In-house)
7.2.3. By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others)
7.2.4. By Drug Type (Generics v/s Innovator)
7.2.5. By Region
7.2.5.1. By State (Top 3 States)
7.2.6. By Company (FY2021)
7.3. Product Market Map

8. India Synthetic Active Pharmaceutical Ingredients Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Organic Synthesis v/s Inorganic Synthesis)
8.2.2. By Source
8.2.3. By Therapeutic Application
8.2.4. By Drug Type

9. India Biological Active Pharmaceutical Ingredients Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Vaccines, Monoclonal Antibodies, Recombinant Proteins, Hormones, Others)
9.2.2. By Source
9.2.3. By Therapeutic Application
9.2.4. By Drug Type

10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. PLI Scheme Analysis for API Production
14. Demand-Supply Scenario
15. India Economic Profile

16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles (Includes SWOT Analysis of Top 5 Companies)
16.2.1. Teva API India Limited
16.2.2. Pfizer Ltd.
16.2.3. Ipca Laboratories Limited
16.2.4. Dr. Reddy’s Laboratories Ltd.
16.2.5. Sun Pharmaceutical Industries Limited
16.2.6. Cipla Limited
16.2.7. Lupin Limited
16.2.8. Aurobindo Pharma Limited
16.2.9. Aarti Drugs Ltd.
16.2.10. IOL Chemicals and Pharmaceuticals Limited
16.2.11. Marksans Pharma Ltd.
16.2.12. Divis Laboratories Ltd.
16.2.13. Granules India Limited
16.2.14. Laurus Labs Ltd.
16.2.15. Solara Active Pharma Sciences Ltd.

17. Strategic Recommendations
18. About Us & Disclaimer

Figure 1: India Active Pharmaceutical Ingredients Market Size, By Value (USD Million), FY2017 – FY2027F
Figure 2: India Active Pharmaceutical Ingredients Market Share, By Method of Synthesis, By Value, FY2017 – FY2027F
Figure 3: India Active Pharmaceutical Ingredients Market Share, By Source, By Value, FY2017 – FY2027F
Figure 4: India Active Pharmaceutical Ingredients Market Share, By Therapeutic Application, By Value, FY2017 – FY2027F
Figure 5: India Active Pharmaceutical Ingredients Market Share, By Drug Type, By Value, FY2017 – FY2027F
Figure 6: India Active Pharmaceutical Ingredients Market Share, By Company, By Value, FY2021
Figure 7: India Active Pharmaceutical Ingredients Market Share, By Region, By Value, FY2017 – FY2027F
Figure 8: West India Active Pharmaceutical Ingredients Market Share, By State, By Value, FY2017-FY2027F
Figure 9: South India Active Pharmaceutical Ingredients Market Share, By State, By Value, FY2017-FY2027F
Figure 10: North India Active Pharmaceutical Ingredients Market Share, By State, By Value, FY2017-FY2027F
Figure 11: East India Active Pharmaceutical Ingredients Market Share, By State, By Value, FY2017-FY2027F
Figure 12: India Synthetic Active Pharmaceutical Ingredients Market Size, By Value (USD Million), FY2017 – FY2027F
Figure 13: India Synthetic Active Pharmaceutical Ingredients Market Share, By Product Type, By Value, FY2017 – FY2027F
Figure 14: India Synthetic Active Pharmaceutical Ingredients Market Share, By Source, By Value, FY2017 – FY2027F
Figure 15: India Synthetic Active Pharmaceutical Ingredients Market Share, By Therapeutic Application, By Value, FY2017 – FY2027F
Figure 16: India Synthetic Active Pharmaceutical Ingredients Market Share, By Drug Type, By Value, FY2017 – FY2027F
Figure 17: India Biological Active Pharmaceutical Ingredients Market Size, By Value (USD Million), FY2017 – FY2027F
Figure 18: India Biological Active Pharmaceutical Ingredients Market Share, By Product Type, By Value, FY2017 – FY2027F
Figure 19: India Biological Active Pharmaceutical Ingredients Market Share, By Source, By Value, FY2017 – FY2027F
Figure 20: India Biological Active Pharmaceutical Ingredients Market Share, By Therapeutic Application, By Value, FY2017 – FY2027F
Figure 21: India Biological Active Pharmaceutical Ingredients Market Share, By Drug Type, By Value, FY2017 – FY2027F